Markets

Oracle's Ellison Scraps 50M Share Sale Plan, Easing Overhang

Larry Ellison has canceled his Oracle stock sale plan, eliminating a potential supply overhang. No shares were sold, and he has no other sale plans.

Daniel Marsh · · · 3 min read · 18 views
Oracle's Ellison Scraps 50M Share Sale Plan, Easing Overhang
Mentioned in this article
ORCL $150.28 -1.74%

In a surprising weekend announcement, Oracle's Executive Chair Larry Ellison has withdrawn a pre-arranged stock trading plan that could have offloaded up to 50 million shares of the company's common stock. The plan, which was scheduled to run through October 24, was terminated before any shares were sold, according to a company statement released Saturday. Ellison has confirmed he has no other active plans to sell his Oracle holdings, a move that removes a significant overhang from the market.

The cancellation eliminates a potential supply of shares valued at approximately $7.51 billion, based on Oracle's closing price of $150.28 on Friday. That figure represents a substantial amount of stock that could have flooded the market, but the reversal does not directly impact Oracle's cash reserves or its capital expenditure plans for AI cloud expansion. Investors will be watching Monday's trading session closely to gauge whether the relief rally materializes and holds.

Plan Details and Market Context

The trading plan, disclosed in Oracle's quarterly filing on Friday, was established on June 22 under Rule 10b5-1, a mechanism that allows insiders to set up predetermined trading schedules to avoid accusations of insider trading. The plan authorized the sale of up to 50 million shares, but such plans do not guarantee that the maximum amount will be sold; they merely set a cap. Oracle's most recent share count stands at approximately 3.02 billion shares as of September 7, making the canceled plan represent 1.65% of the company's outstanding shares.

Friday's trading volume was 78.5 million shares, meaning the potential sale could have been equivalent to 63.7% of that day's activity, although actual sales would have been spread across multiple sessions and subject to the plan's undisclosed restrictions. The news of the cancellation comes after Oracle's shares fell 1.7% on Friday, and there has been no U.S. market reaction yet due to the weekend announcement.

Investor Implications

The immediate bullish interpretation is that investors no longer need to factor in a large founder sale into a stock that is already absorbing heavy financing and post-earnings volatility. Ellison's continued alignment with shareholders is seen as a positive signal. However, Oracle did not provide a reason for the cancellation, so attributing the decision to a change in business outlook would be speculative.

More importantly, this was a personal sale plan by Ellison, not a company action. Its cancellation does not reverse Oracle's own capital-raising activities, including the $20 billion in common stock issued through an at-the-market program during the August quarter. The company's financing framework for calendar 2026 remains unchanged, targeting $45 billion to $50 billion in gross proceeds to fund cloud capacity expansion.

Operational Fundamentals Remain Key

Oracle's operating story is robust on the demand side. In its fiscal first-quarter release, the company reported remaining performance obligations of $664 billion, driven by over $30 billion in new AI cloud contracts. Additionally, Oracle delivered more than 300,000 GPUs to cloud customers during the quarter, underscoring the strength of its AI infrastructure business.

However, the cash conversion picture is less favorable. Oracle's 10-Q filing revealed operating cash flow of $23.10 billion and capital expenditures of $28.50 billion for the quarter, resulting in a cash deficit of approximately $5.40 billion. The cancellation of Ellison's sale plan changes the prospective market supply but does nothing to close this cash gap.

Monday's trading will provide a clear test of investor sentiment. A higher opening price would indicate that the market assigns real weight to the removed overhang. Yet, a sustained re-rating will require evidence that the $664 billion backlog can convert into revenue and cash at a pace that justifies the company's financing burden. The simplest counterargument to a large move is that no shares were actually sold, so Oracle's business and balance sheet remain exactly where they were on Friday.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →